Fact CheckerSign in

NCT05149144Completed

Comutti - A Research Project Dedicated to Finding Smart Ways of Using Technology for a Better Tomorrow for Everyone, Everywhere.

Source: ClinicalTrials.gov · Last updated 13 May 2025

Brief summary (registry, in English)

According to World Health Organization, worldwide one in 160 children has an ASD. About around 25% to 30% of children are unable to use verbal language to communicate (non-verbal ASD) or are minimally verbal, i.e., use fewer than 10 words (mv-ASD). The ability to communicate is a crucial life skill, and difficulties with communication can have a range of negative consequences such as poorer quality of life and behavioural difficulties. Communication interventions generally aim to improve children's ability to communicate either through speech or by supplementing speech with other means (e.g., sign language, pictures, or AAC - Advanced Augmented Communication tools). Individuals with non- verbal ASD or mv-ASD often communicate with people through vocalizations that in some cases have a self-consistent phonetic association to concepts (e.g., "ba" to mean "bathroom") or are onomatopoeic expressions (e.g., "woof" to refer to a dog). In most cases vocalizations sound arbitrary; even if they vary in tone, pitch, and duration depending it is extremely difficult to interpret the intended message or the individual's emotional or physical state they would convey, creating a barrier between the persons with ASD and the rest of the world that originate stress and frustration. Only caregivers who have long term acquaintance with the subjects are able to decode such wordless sounds and assign them to unique meanings. This project aims at defining algorithms, methods, and technologies to identify the communicative intent of vocal expressions generated by children with mv-ASD, and to create tools that help people who are not familiar with the subjects to understand these individuals during spontaneous conversations.

Status (registry)
Completed
Study type
Interventional
Enrollment
33 (actual)
First submitted
25 Nov 2021
Start date
27 Jul 2021
Primary completion date
31 Dec 2024
Lead sponsor
IRCCS Eugenio Medea
Diseases
Autism
NCT number
NCT05149144

What you commit to

  • Study type: Interventional
  • Participants enrolled: 33
  • From 27 Jul 2021 to the primary completion date, 31 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • using any stimulant or non-stimulant medication affecting the central nervous system

Other illness

  • having an identified genetic disorder
  • suffering from chronic or acute medical illness

Other

  • having vision or hearing problems

Who the study is looking for

  • having a clinical diagnosis of autism spectrum disorder according to DSM-5 criteria
  • use fewer than 10 words

Age in the registry: 2 years to 10 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Scientific Institute IRCCS Eugenio Medea
Coordinator of this site? Confirm its status
Bosisio PariniItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.